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duced similar increased GAG and collagen release as when
co-incubated with cytokines. APC markedly increased MMP-2
activation (>80%) in IL-1 and TNF, but not RA treated cultures,
despite elevated pro-MMP-2 levels in the latter. APC increased
MMP-13 activity in IL-1 and TNF but not RA media, but could
not directly activate recombinant pro-MMP-13. APC did not sig-
nificantly modulate ADAMTS, MMP or TIMP expression when
administered alone or in combination with IL-1, TNF or RA.
Chondrocytes expressed mRNA for PC, EPCR and TM and
levels were not affected by APC or RA treatment. However,
IL-1 and TNF increased EPCR (1.7 & 3.8 fold, respectively)
and TM (5 and 18 fold, respectively) expression. PC was im-
munolocalised to chondrocytes in the presumptive joint space
prior to cavitation, the hypertrophic zone of the growth plate,
and throughout the depth of the cartilage in OA but not normal
joints.
Conclusions: Our results demonstrate that APC can act as an
efficient activator of MMPs in cartilage, inducing significant ag-
grecan and collagen degradation. Chondrocytes have previously
been shown to synthesise thrombin, and we have now demon-
strated that they express PC EPCR and TM necessary for its
efficient activation. PC was immunolocalised to chondrocytes in
areas of known MMP activity in growth cartilages and was in-
creased in OA. Catabolic cytokines known to be involved in OA
increased expression of TM and EPCR. Taken together, these
results suggest that APC may be a physiologically important
activator of MMPs in cartilage and regulating its activity could be
a novel target in the treatment of cartilage breakdown in arthritis.
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Purpose: The elevated levels of injury-induced pro-inflammatory
cytokines in the joint may play pivotal roles in the pathogenesis
of osteoarthritis. The objective of this study was to examine the
combined effects of TNF-α and IL-6/sIL6R on proteoglycan (PG)
degradation in mechanically-injured cartilage.
Methods: Immature bovine cartilage disks (3 mm diam, 1 mm
thick) from femoropatellar grooves were treated with either injuri-
ous compression (50% strain, 100%/second strain rate), rhTNF-α
(25 ng/ml), rhIL-6 (50 ng/ml) plus sIL-6R (250ng/ml), or combi-
nations of these three conditions. Culture was terminated after
6 days of treatment. In separate experiments, half the cartilage
disks were pre-equilibrated for 6 days with an IL-6 blocking Fab
fragment (50 ug/ml, Centocor, J&J) while the remaining disks
were incubated in normal medium. Afterward, disks were treated
with injurious compression, rhTNF-α (25 ng/ml), or injury + TNF-
α. Disks that were pre-treated with the Fab fragment continued to
receive it until the end of the experiment. sGAG release (DMMB)
and biosynthesis (35S-PG) were measured, and Western blot-
ting to identify G1-NITEGE aggrecan fragments was performed
on pooled medium. Selected cartilage samples were fixed in
gluteraldehyde (with RHT) and stained with Toluidine Blue.
Results: 3-way ANOVA followed by post-hoc Tukey’s pairwise
comparisons showed that TNF-α formed interactions with both
IL-6/sIL-6R and injurious compression causing increased sGAG
release and decreased PG synthesis. While IL-6/sIL-6R signif-
icantly augmented TNF-α-induced PG degradation, the largest
amount of GAG loss was caused by the combination of injury +
TNF-α + IL-6/sIL-6R. Histology showed that GAG loss was not
uniform in the disk cross-section but progressed from the disk
periphery towards the center with time. The most rapid, severe
GAG loss was observed in disks treated with the combination
of injury + TNF-α + IL-6/sIL-6R. Western blotting demonstrated
that the most dramatic release of aggrecanase-generated aggre-
can fragments occurred in response to treatment with TNF-α +
IL-6/sIL-6R, both with and without injurious compression. In sep-
arate studies, TNF-α + mechanical injury caused greater GAG
loss than either treatment alone. Importantly, the IL-6 blocking
Fab fragment significantly reduced the combined catabolic effects
of TNF-α + mechanical injury on GAG loss, with no exogenous
IL-6 present.
Conclusions: The combined treatment with TNF-α and IL-6/sIL-
6R induced significantly more GAG loss than either cytokine
alone, and this catabolic response was associated with aggre-
canase activity. Additionally, the catabolic effect of TNF-α, and
the combined effect of TNF-α + IL-6/sIL-6R are both highly po-
tentiated by mechanical injury. The degradative effects of injury
+ TNF-α appear to be due, in part, to the action of endogenous
IL-6, as sGAG loss was partly abrogated by the IL-6 blocking
Fab fragment. This result is also consistent with the increased
loss of sGAG upon addition of exogenous IL-6 to the combi-
nation of TNF-α and mechanical injury. Histology suggests that
the kinetics of cartilage degradation does not merely depend
on the activity of proteolytic enzymes, but also relies strongly
on the transport of cartilage biomolecules, which may be al-
tered by overload injury. In conclusion, this study suggests that
pro-inflammatory cytokines can interact to potentiate cartilage
catabolism. Chondrocyte-mediated catabolism, as well as trans-
port of cytokines and proteases in the matrix, may both be altered
by joint injury, making the damaged tissue more susceptible to
further degradation by biochemical mediators.
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Purpose: Calcitonin has recently been proposed as an effective
drug for the treatment of osteoarthritis (OA). We investigated
whether treatment with salmon calcitonin influences the local
content of proteoglycans in human OA articular cartilage and
whether treatment with oral salmon calcitonin effects articular
cartilage erosion in an in vivo experimental model of OA.
Methods: For investigations of chondrocyte-mediated effects of
salmon calcitonin we used human OA cartilage obtained from
knee arthroplasty operations, which was dissected into 12-14
mg explants and cultured for 16 days in four replicates with
refreshment of medium every second day in the presence or
absence of salmon calcitonin [1 nM-1 mM]. MMP-13 ELISA was
used to quantify MMP-13 activity in the conditioned medium, and
sulphated glycosaminoglycan (sGAG) was measured in N2 pul-
verized explants extracts by the alcian blue binding assay. The
ovariectomized (OVX) rat was used as a non-traumatic model
of accelerated cartilage loss accompanying estrogen deficiency.
Fifty rats were randomly allocated into five intervention groups
and treated for nine weeks: 1) Sham, 2) OVX, 3) OVX + s.c.
implanted 17-β-ethynyl-estradiol pellet, 4) OVX + daily oral dose
calcitonin [2 mg/kg] + vehicle, 5-CNAC [50 mg/kg], and 5) OVX
+ daily oral dose of vehicle 5-CNAC [50 mg/kg]. Extracts of
entire articular joints was used for biochemical analysis. The
articulatio cubiti joint were isolated, snap-frozen, pulverized in N2
and resuspended with protease inhibitors, and fragments of C-
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telopeptides of collagen type II was quantified by CTX-II ELISA.
Articular cartilage erosion was scored using histology after tolu-
idine blue staining of proteoglycans of the tibial and femoral
plateau, where the eroded surface was quantified relative to the
entire articular surface.
Results: Treatment of human OA cartilage explants with 100
nM salmon calcitonin significantly (P<0.05) inhibited MMP-13
release from human articular cartilage explants by 38%. Extracts
of pulverized human OA explants cultured with calcitonin had
significantly higher levels of total proteoglycan pr. mg cartilage
than control explants cultured without salmon calcitonin, 1 mM
and 1 nM (P<0.01); 10 nM and 100 nM (P<0.05). In vivo,
scoring of cartilage erosion by histology showed significantly
more surface erosion in the OVX+vehicle group compared that
of the sham oprated animals (112%, P<0.01). Treatment with
oral calcitonin or estrogen completeley reverted this to sham
levels (P<0.01). In joint extracts, ovariectomy resulted in 100%
increased cartilage degradation products compared to sham
operated animals. Treatment with oral salmon calcitonin restored
this increase to sham levels.
Conclusions: In human OA articular cartilage, calcitonin de-
creased MMP-13 levels and furthermore increased proteoglycan
content. The demonstrated in vivo effects indicate that calci-
tonin counteract the slow progression of cartilage degradation
in a non-traumatic model of OA. The chondroprotective effect
of salmon calcitonin may be a combination of direct effects on
chondrocytes in addition to the well-established effect on bone
resorption.
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Purpose: Lumbar degenerative disc disease (LDD) forms part
of the spine osteoarthritis (OA) phenotype and is known to
be influenced by genetic factors. Using healthy twin volunteers
we have shown both extent and severity scores of LDD on
lumbar spine MRI scan to have heritability >70%. We studied
dizygotic (DZ) twins having lumbar MRI scans from the previous
heritability study and performed a genome-wide linkage study to
determine whether specific chromosomal regions are linked with
LDD. Twins offer particular advantages for the study of an age-
related phenotype such as this: not only are twins within a pair
age-matched, they are more closely matched for environmental
factors than normal sib-pairs.
Methods: Ethics committee approval and patient consent were
obtained. Dizygotic twins (N = 338) from the TwinsUK register
who underwent MRI scanning of the lumber spine 10 years
ago were identified. DNA was isolated from venous blood by
standard technique. Genotyping included 737 highly polymor-
phic microsatellite markers spaced every 10 cM. The estimated
genotyping error was <1%.
Multipoint genome-wide linkage analysis was conducted using
generalized linear modeling based on optimal Haseman and
Elston methods in which the square of the sibling difference
in OA phenotype (age-adjusted) is regressed on the estimated
proportion of alleles identical-by-descent (IBD). An empirical p-
value was estimated using a permutation approach in which
1,000 permutations of the dataset were performed for each LOD
score, keeping IBD and family structure in tact.
Results: DZ twins were female and had mean age = 52 years.
Linkage peaks (defined as maximum LOD > 3) were identified
for LDD severity at three chromosomal regions. These included
chromosome 1 (position 285 cM), chromosome 5 (position 175
cM) and chromosome 19 (position 80 cM). The peak on chro-
mosome 19 had LOD = 4.06 and the empirical p = 6.7 x 10-4
confirmed reliability of the linkage signal. A peak at a similar po-
sition on chromosome 19 has also been identified with hand OA
in TwinsUK volunteers. This phenotype used a composite score
derived from assessment of distal- and proximal interphalangeal
joints and carpometacarpal joints.
Conclusions: LDD is known to be influenced by genetic factors.
This is the first genome-wide linkage study of LDD and shows
evidence of a linkage peak on chromosome 19. Of interest, we
have found a similarly positioned peak for hand OA (in press),
work which replicates the findings of others (Demissie et al
2002). The region of interest is large and is estimated to contain
∼300 genes. These results suggest that there are predisposing
genes common to hand OA and LDD in this region and fine
mapping this area would be a reasonable next step.
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Purpose: The ank-/ank- mouse is a spontaneous genetic mouse
strain in which calcific deposits form in synovial joints with sub-
sequent bone formation in peri-articular tissues leading to anky-
losis. The purpose of the present study is to determine the
sequence of morphologic and morphometric changes in chon-
drocyte histology within synovial joints of the ank-/ank- mouse.
Methods: Using 5μm Hematoxylin and Eosin sections from
formalin fixed, paraffin embedded, decalcified bones (upper ex-
tremity, lower extremity), we analyzed the cartilage histological
features of joints in 22 mice: 11 homozygotes (ank-/ank-), 5 het-
erozygotes (ank-/ank+) and 6 controls (ank+/ank+), ranging in age
from 7 weeks to 18 weeks. Cartilage morphometry to determine
the size distribution of chondrocytes was performed on knee joint
articular cartilage using a Visiopharm image analysis system.
Results: ank-/ank- mice display similar histologic changes in
all synovial joints with most advanced disease present in the
most peripheral joints. We found that the earliest cartilage mor-
phologic and morphometric change appears to be chondrocyte
hypertrophy in the distal joints of ank-/ank-mice.
This is followed by precipitation of calcific material in the synovial
space and within synovium. Later, cartilage metaplasia of the
Fig. 1. Knee joint, articular cartilage, ank-/ank- mouse. The cartilage is thicker
and the chondrocytes larger than the control (Fig. 2). Figure width = 100 μm.
